Medical Knowledge Group Appoints Christie Mealo as Chief AI Officer
This appointment reflects MKG's continued investment in advancing its technology and AI capabilities across the organization and its client solutions. AI has long been embedded in how MKG develops insights, builds solutions, and supports decision-making, and this role formalizes and scales those efforts across the business.
Mealo brings more than a decade of experience building and scaling AI-driven products. Most recently, she served as Senior Vice President of AI Products at 90NORTH (IPG Health), where she launched a first-to-market AI product suite that generated more than
"Christie brings deep experience in building AI-driven solutions at scale," said
Mealo is also the founder of Philly Data & AI, a 2,500+ member technology community, and is currently writing a forthcoming book on AI product strategy.
"I'm excited to join MKG at a time when AI is becoming increasingly central to how organizations operate and create value," said
About Medical Knowledge Group
Medical Knowledge Group (MKG) provides integrated services to pharmaceutical and biotechnology companies, including medical communications, market access strategy, market research, brand engagement, and data & analytics.
Media Contact
Medical Knowledge Group
[email protected]
View original content:https://www.prnewswire.com/news-releases/medical-knowledge-group-appoints-christie-mealo-as-chief-ai-officer-302738309.html
SOURCE Medical Knowledge Group
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Monster Energy's Mackenzie Dern Defends Women's UFC Strawweight Championship Title at UFC 330 in Philadelphia
- BNB Chain Presale: MemeToro Advances AI Launchpad Plans Alongside Grayscale’s Spot BNB ETF Filing
- APIC delivers 55% EBITDA growth in the first half of 2026, reaching USD 44 million
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share